A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance with Olaparib or Placebo for the First-Line Treatment of BRCA non-mutated Advanced Epithelial Ovarian Cancer (EOC)

Project: Research

Project Description



StatusActive
Effective start/end date20/09/1919/09/24

Keywords

  • clinical trial
  • treatment efficacy
  • phase 3 study
  • ovarian cancer